Allogene Therapeutics Inc (NASDAQ: ALLO): Is It Possible To Be Down -5.16% YTD And Still Lose Money
During the last session, Allogene Therapeutics Inc (NASDAQ:ALLO)’s traded shares were 2.42 million, with the beta value of the company hitting 0.89. At the end